carbidopa has been researched along with piribedil in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (83.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Quik, M; Sourkes, TL | 1 |
| Agnoli, A; Carolei, A; Casacchia, M; Fazio, C; Zamponi, A | 1 |
| Chase, TN; Shoulson, I | 1 |
| Agnati, L; Fuxe, K; Hökfelt, T; Löfstöm, A | 1 |
| Cheal, M | 1 |
1 trial(s) available for carbidopa and piribedil
| Article | Year |
|---|---|
Clonidine and the anti-parkinsonian response to L-DOPA or piribedil.
Topics: Aged; Carbidopa; Clinical Trials as Topic; Clonidine; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Piperazines; Piribedil; Placebos | 1976 |
5 other study(ies) available for carbidopa and piribedil
| Article | Year |
|---|---|
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Central dopaminergic and serotoninergic systems in the regulation of adrenal tyrosine hydroxylase.
Topics: 5-Hydroxytryptophan; 5,6-Dihydroxytryptamine; Adrenal Glands; Animals; Apomorphine; Bromocriptine; Carbidopa; Clonidine; Dopamine; Drug Interactions; Haloperidol; Hydroxydopamines; Injections, Intraventricular; Kinetics; Levodopa; Male; Piribedil; Pituitary Gland; Rats; Serotonin; Serotonin Antagonists; Splanchnic Nerves; Tyrosine 3-Monooxygenase | 1977 |
[Therapy of Parkinson's disease. Practical criteria of treatment].
Topics: Amantadine; Antiparkinson Agents; Benserazide; Carbidopa; Cyproheptadine; Drug Therapy, Combination; Histamine H1 Antagonists; Humans; Levodopa; Parasympatholytics; Parkinson Disease; Piribedil; Pizotyline; Propranolol | 1976 |
Dopaminergic drugs and ovulation: studies on PMS-induced ovulation and changes in median eminence DA and NE turnover in immature female rats.
Topics: Animals; Apomorphine; Carbidopa; Dopamine; Ergot Alkaloids; Female; Gonadotropins, Equine; Hypothalamo-Hypophyseal System; Levodopa; Lysergic Acid Diethylamide; Median Eminence; Norepinephrine; Ovulation; Piribedil; Pregnancy; Rats; Receptors, Adrenergic; Receptors, Dopamine | 1977 |
L-Dopa and piribedil alter different components of attentional behavior dependent on dose.
Topics: Animals; Attention; Behavior, Animal; Carbidopa; Dose-Response Relationship, Drug; Exploratory Behavior; Female; Gerbillinae; Levodopa; Male; Motor Activity; Piperazines; Piribedil; Time Factors | 1983 |